| 摘要 |
Use of a bacterial strain or an active derivative, fragment or mutant thereof which selectively upregulates the production of nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin 3 (NT3) or neurotrophin 4 (NT4) in the treatment and/or prophylaxis of various disorders especially inflammatory disorders. The bacterial strain may be a Lactobacillus especially, Lactobacillus reuteri. |
